RSRC2 and gastric adenocarcinoma: Other, rarer fusions were also identified, including GAS7-MYH1 and ZCCHC8-RSRC2, each of which were identified in 4 ILD samples and have been reported previously in cancer samples (GAS7-MYH1 in lung and stomach adenocarcinoma, and ZCCHC8-RSRC2 in multiple cancers) [52].